Literature DB >> 21725676

Management of recurrent vault prolapse.

V V Toh1, V Bogne, A Bako.   

Abstract

In the ageing female population, recurrent vaginal vault prolapse is a significant healthcare burden. There is limited evidence regarding the optimal management strategy for recurrent vault prolapse. This paper aims to discuss treatment modalities available for recurrent vault prolapse. A literature search and analysis was performed using Medline, PubMed, Cochrane database, current texts and references from relevant articles. We found inconclusive evidence supporting conservative, mechanical and some surgical options for treating recurrent vault prolapse; including iliococcygeal fixation, McCall culdoplasty, and infracoccygeal sacropexy. Sacrospinous ligament fixation (SSLF), sacrocolpopexy, mesh implants and colpocleisis are shown to have good outcomes in Level II studies. Nevertheless, the first two are associated with haemorrhage, dyspareunia and scarring whilst colpocleisis is limited to selected patients. More well-designed studies are required for recurrent vault prolapse. Current evidence suggests SSLF, and sacrocolpopexy are alternative surgical options to colpocleisis in treating recurrent vault prolapse. Randomised trials are required to determine the efficacy and safety of trocar-guided mesh kits.

Entities:  

Mesh:

Year:  2011        PMID: 21725676     DOI: 10.1007/s00192-011-1487-z

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  37 in total

1.  Gynecologists' patterns of prescribing pessaries.

Authors:  E Pott-Grinstein; J R Newcomer
Journal:  J Reprod Med       Date:  2001-03       Impact factor: 0.142

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

3.  [Risk factors for prosthesis exposure in treatment of genital prolapse via the vaginal approach].

Authors:  F Belot; P Collinet; P Debodinance; E Ha Duc; J-P Lucot; M Cosson
Journal:  Gynecol Obstet Fertil       Date:  2005-12

4.  Uterosacral ligament vault suspension: five-year outcomes.

Authors:  W Andre Silva; Rachel N Pauls; Jeffrey L Segal; Christopher M Rooney; Steven D Kleeman; Mickey M Karram
Journal:  Obstet Gynecol       Date:  2006-08       Impact factor: 7.661

Review 5.  Conservative management of pelvic organ prolapse in women.

Authors:  S Hagen; D Stark; C Maher; E Adams
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

6.  Total colpocleisis for vaginal eversion.

Authors:  J O DeLancey; G W Morley
Journal:  Am J Obstet Gynecol       Date:  1997-06       Impact factor: 8.661

7.  Perioperative course and medium-term outcome of the transobturator and infracoccygeal hammock for posthysterectomy vaginal vault prolapse.

Authors:  Fabrice Sergent; Joël Zanati; Violène Bisson; Nicolas Desilles; Benoît Resch; Loïc Marpeau
Journal:  Int J Gynaecol Obstet       Date:  2010-01-22       Impact factor: 3.561

8.  Abdominal mesh sacrocolpopexy for recurrent triple-compartment pelvic organ prolapse.

Authors:  Jason P Gilleran; Philippe Zimmern
Journal:  BJU Int       Date:  2009-01-20       Impact factor: 5.588

9.  Retrospective multicentre study of the new minimally invasive mesh repair devices for pelvic organ prolapse.

Authors:  M Abdel-Fattah; I Ramsay
Journal:  BJOG       Date:  2008-01       Impact factor: 6.531

10.  Trocar-guided total tension-free vaginal mesh repair of post-hysterectomy vaginal vault prolapse.

Authors:  Alfredo L Milani; Mariella I J Withagen; Mark E Vierhout
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-05
View more
  1 in total

1.  3D simulation of pelvic system numerical simulation for a better understanding of the contribution of the uterine ligaments.

Authors:  C Rubod; P Lecomte-Grosbras; M Brieu; G Giraudet; N Betrouni; M Cosson
Journal:  Int Urogynecol J       Date:  2013-08-20       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.